New Issue Published Current Cancer Drug Targets Vol 18 issue 1
...
Monday, December 11, 2017
Monday, October 16, 2017
Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
...
Thursday, October 12, 2017
New Issue Published Current Cancer Drug Targets Vol 17 issue 9
New Issue Published Current Cancer Drug Targets Vol 17 issue 9
...
Monday, October 9, 2017
Monday, October 2, 2017
Most Accessed Article : Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review
Most Accessed Article : Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review
...
Monday, September 25, 2017
New Issue Published Current Cancer Drug Targets Vol 17 issue 8
New Issue Published Current Cancer Drug Targets Vol 17 issue 8
...
Tuesday, August 22, 2017
Tuesday, August 15, 2017
Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
...
Thursday, August 10, 2017
New Issue Published Current Cancer Drug Targets Vol 17 issue 7
New Issue Published Current Cancer Drug Targets Vol 17 issue 7
...
Sunday, August 6, 2017
Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
...
Monday, July 31, 2017
Monday, July 17, 2017
Monday, July 3, 2017
Most Accessed Article:Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Most Accessed Article:Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
...
New Issue Published Current Cancer Drug Targets Vol 17 issue 6
New Issue Published Current Cancer Drug Targets Vol 17 issue 6
...
Monday, June 12, 2017
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles"
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles"
...
Sunday, June 4, 2017
Sunday, May 28, 2017
Monday, May 22, 2017
Most Accessed Article Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Most Accessed Article : Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
...
Thursday, May 18, 2017
Tuesday, May 9, 2017
Open Access Article: Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
Open Access Article: Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
...
Tuesday, April 18, 2017
Thursday, April 13, 2017
Wednesday, April 5, 2017
Open Access Article: Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition
Open Access Article: Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition
...
Wednesday, March 22, 2017
Most Accessed Article: Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Most Accessed Article: Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
...
Thursday, March 16, 2017
Wednesday, March 8, 2017
Wednesday, March 1, 2017
Open Access Article: Pleiotropic Role of HSF1 in Neoplastic Transformation
Open Access Article: Pleiotropic Role of HSF1 in Neoplastic Transformation
...
Tuesday, February 28, 2017
New Issue Published Current Cancer Drug Targets Vol. 17 Issue 3
New Issue Published Current Cancer Drug Targets Vol. 17 Issue 3
...
Monday, February 20, 2017
Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
...
Wednesday, February 1, 2017
Free Online Issue Current Cancer Drug Targets Vol. 17 Issue 1
Free Online Issue Current Cancer Drug Targets Vol. 17 Issue 1
...
Wednesday, January 25, 2017
Wednesday, January 18, 2017
Wednesday, January 11, 2017
New Issue Published Current Cancer Drug Targets Vol. 17 Issue 2
New Issue Published Current Cancer Drug Targets Vol. 17 Issue 2
...
Tuesday, January 3, 2017
Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
...
Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
...
Open Access Article: A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Open Access Article: A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
...
